4A3360).
Introduction
The intracellular sites of synthesis, storage, and transport of the phospholipids are much more difficult to idenufy by light and electron microscopic cytochemistry than those of the proteins. Autoradiographic detection ofphospholipids (Maraldi et al., 1981; Boyenval and Droz, 1976; Stein and Stein, 1971) , in addition to being a timeconsuming and not easily reproducible technique, seldom allows detection of single phospholipid types, since many phospholipids derive from an enzymatic substitution of the polar head of phosphatidylcholine. Moreover, cytochemical stainings for phospholipids are not very specific and do not allow quantitative evaluations (Lawton, 1989; Kao and Lichtenberger, 1987) . A recently reported enzyme-gold technique, based on the use of phospholipases, has demonstrated the possibility of identifying cell phospholipids in indicate that PIP2 is localized at precise intranuclear sites both in in situ and in isolated nuclei. They also show that a significant amount of the phospholipid is retained by the cytoskeleton and by the inner nuclear matrix in in situ matrix preparations. Moreover the sensitivity of the immunocytochemical reaction is capable of detecting quantitative variations of PIP2 nuclear content induced by agonists that modulate the signal transduction system at the nuclear level. (J Histochem Cytochem 1995) KEY WORDS: Signal transduction; Phosphatidylinositol 4,5bisphosphate; Immunogold labeling; Isolated nuclei; Nuclear matrix; Friend cells; Rat pancreas; 3T3 cells. membrane structures (Kan, 1993; Codombe et al., 1988) and within the nucleus (Maraldi et al., 1992) . This method, however, does not allow identification of individual molecular species, since it reacts with the whole set of phospholipids.
The low antigenic properties of the phospholipids, and the crossreactivity of the available antibodies with other phosphorylated molecules (Koike et al., 1990) , as well as the difficulty in obtaining phospholipid fixation and in preserving their antigenic properties (Voorhout et al.. 1992) , have severely limited application of immunocytochemical techniques (Butor et al., 1991; Kanai et al., 1990; Boddingius and Dijkman, 1989; Knoll et al., 1988) .
The use of monoclonal antibodies (MAbs) that recognize phos-phatidylinositol4,5-bisphosphate (PIP2) appears to offer the possibility for selective identification of the intracellular sites at which this phospholipid is present (Voorhout et al., 1992; Fukami et al., 1988; Miyazawa et al., 1988) . PIP2, which derives from the phosphorylation of phosphatidylinositol (PI), represents a key element of the signal transduction system within the cell (Berridge and Irvine, 1984) . Phosphorylation of PI to phosphatidylinositol 4-phosphate (PIP) and PIP2 was originally thought to be limited to the plasma membrane or to the endoplasmic reticulum (Helms et al., 1991) . It has been shown, however, that the polyphosphoinositide MAZZOTTI, ZINI, RIZZI, RIZZOLI, GALANZI, OGNIBENE. SANTI, MAlTEUCCI, MARTELLI, MARALDI synthesis also occurs at the nuclear level and takes place not only on the nuclear membrane (Smith and Wells, 1983) but even within the nucleus (Cocco et al., 1987) . since the specific phosphoinositide kinases are bound to the nuclear matrix fractions (Payrastre et al., 1992) . Furthermore, the existence of a phospholipid signal transduction cascade based on the polyphosphoinositide breakdown has been corroborated by the discovery in the nucleus of phospholipase C isoforms and of protein kinase C (Martelli et al., 1992; Divecha et al., 1991) .
Since MAbs that were developed to identify PIP2 in cell membranes (Fukami et al., 1988) , have been reported to detect PIP2 not only in the nuclear membrane (Xan et al., 1993) but also within the nucleus (Voorhout et al., 1992) , we attempted to identify the nuclear sites of PIP2 localization. The results demonstrate that PIP2 identification by means of immunochemical and immunocytochemical procedures with confocal and electron microscopy is specific and efficient, suggesting that the technique can be applied to the study of polyphosphoinositide signal transduction at the nuclear level.
Materials and Methods
Sources of Materials. Culture media and sera were from ICN Flow (Costa Mesa, CA). The electrophoresis reagents and Trans-Blot nitrocellulose membrane were from BioRad (Richmond, CA). Protease inhibitors were from Boehringer (Mannheim, Germany). All other products were from Sigma (St Louis, MO).
Cell Cultures. Murine erythroleukemia cells (Friend cells, clone 707)
were grown in RPMI 1640 medium supplemented with 10% fetal calf senun (FCS). To induce erythroid di&rentiation. 1.5% (vlv) DMSO was added to the medium for 4 days. Swiss 3T3 mouse fibroblasts were grown in Dulbecco's modified minimum essential medium supplemented with 10% FCS for 6 days.
Nudear and Nudear Matrix Isolation. Rat livers were homogenized in 0.25 M sucrose, 5 mM MgC12, 0.5 mM phenylmethylsulfonylfluoride (PMSF), 0.5 mM dithiothreitol (MT), 10 mM Tris-HC1, pH 7.4, in a glass-Tdon homogenizer, filtered through four layers of cheesecloth, and sedimented at 700 x g for 15 min at 4'C. The crude nuclear pellet was re-suspended in 2.4 M sucrose, 5 mM MgC12, 0.5 mM PMSF, 0.5 mM MT, 10 mM Tris-HC1, pH 7.4, and sedimented at 50,000 x g for 1 hr at 4'C. The dear nudear pellet was washed with homogenization buffer by sedimentation at 700 x g. Membrane-depleted nuclei were obtained by adjusting the sucrose density buffers to 0.2% with Triton X-100. The membranes of intact nuclei were permeabilized by 0.2% Triton X-100 after 1% formaldehyde fixation, or by freezing and thawing in liquid nitrogen.
Friend cells, washed in PBS, pH 7.4, were re-suspended in 10 mM Tris-HCI, pH 7.4, 2 mM MgC12,O.S mM PMSF. 10 p g / d Leupeptin, 0.3 pglml aprotinin, 17 pg/ml calpain I inhibitor, 7.5 pg/ml calpain I1 inhibitor for 5 min at O' C. After addition of 0.3% Triton X-100, the cells were sheared through a 22-gauge needle in a plastic syringe. Mg" concentration was raised to 5 mM and nuclei were separated by low-speed centrifugation (400 x g for 8 min).
Nuclear matrices were obtained by re-suspending Friend cell nuclei in 10 mM Tris-HC1. pH 8.0, 5 mM Mg& 2 mM sodium teuathionate ( N m ) for 1 hr at O' C. The sample was then digested with 30 U DNAse I (EC 3.1.21.1)lmg DNA for 1 hr at O' C and an equal volume of 4 M NaCl was added before centrifuging at 1000 x g for 10 min. All the buffers contained the protease inhibitors reported above.
In Situ Matrix Preparations. Swiss 3T3 mouse fibroblasts adhering to the glass substrate were permeabilized for 10 min at room temperature (RT) in 10 mM Tris-HC1, pH 7.4, 5 mM MgC12. 150 mM NaCl (TSM buffer), 1% Nonidet P40, and 2 mM N a n . After two washings with TSM buffex. the cells were digested with DNAse I (20 Ulml TSM) at RT for 1 hr and then extracted twice with 2 M NaCl in TSM for 5 min each. All the buffers contained the protease inhibitors reported above.
Confocal Microscope Immunofluorescence. Rat liver nuclei were fixed with 4% paraformaldehyde in PBS, washed, and settled on glass slides. After treatment with 3% BSA for 30 min at RT, the samples were incubated with anti-PIP2 KT 10 MAb (a generous gift of Dr. T. Wenawa, Tokyo, Japan) diluted 1:lOOO in PBS containing 3% BSA for 2 hr at 37'C and then with a secondary antibody (Fab2 fragment) (Dako; Copenhagen, Denmark), conjugated with F I X diluted 1:10 for 1 hr at RT and washed in PBS. Single optical sections and merged reconstructions were carried out by a Sarastro Phoibos 1000 (Molecular Dynamics; Sunnyvale, CA), as previously reported (Zini et al., 1993) .
Immunoblotting and Immunoprecipitation. For immunoblotting analysis, nuclear protein (200 pg) was separated on a 12% or 10% polyacrylamide plus 0.1% sodium dodecyl sulfate gel and then electrophoretically transferred to 2.5 x 8.5 cm pieces of nitrocellulose paper in 0.192 M glycine, 0.025 M Tris, 20% methanol, pH 8.3 , at 4'C for 24 hr at 50 V (constant). Equal strips were then cut from the nitrocellulose pieces and saturated overnight at 4°C in PBS, pH 7.4, containing either 5% dried milk or 10% normal goat serum (NGS), 4% BSA. In some cases, before saturation the strips were incubated for 30 min at 4°C in 1% glutaraldehyde in 0.1 M phosphate buffer, followed by four washes in PBS. Strips were reacted for 6 hr at RT with KT 10 MAb, diluted in PBS. 10% NGS, 4% BSA, washed four times in PBS, 0.1% BSA, and reacted for 1 hr at RT in PBS, 0.1% BSA containing a 1:lOOO dilution of an alkaline phosphatase-conjugated anti-mouse IgG (Sigma). After four washes as above, antibody binding was detected in 100 mM Tris-HC1, pH 9.6, 4 mM MgC12, 0.1 mg/mlp-nitrotetrazolium blue, 0.05 mg/ml 5-bromo-4-chloro-3-indolyl phosphate. For dot-blot analysis, 5 pg each of PI, PIP, and PIP2 (dissolved in chloroform-methanol) was spotted onto nitrocellulose strips, which were then saturated and treated with anti-PIP2 antibody as outlined above. For immunoprecipitation analysis, 100 pg of the anti-PIP2 MAb was shaken with 100 pg of histones (Histone Type IIIS, lysine-rich fraction from calf thymus; Sigma) for 1 hr at RT, followed by 1 hr of incubation with protein A-Sepharose CL-4B (10% w/v). Immunocomplexes were collected by centrifugation and run on 7.5% gels.
Electron Miaoscopic Immunocytochemistry. The samples (rat pancreas, Friend cell isolated nuclei and nuclear matrices, and in situ 3T3 matrix preparations) were processed for both Lowicryl KM 20 and I X White embedding.
For Lowicryl embedding the samples were fixed in 2% paraformaldehyde in 0.1 M phosphate buffer for 1 hr at 4'C, cryoprotected in 2.3 M sucrose in the same buffer, and transferred to liquid nitrogen. Freezesubstitution was carried out at -9 o T for 48 hr in methanol containing 0.5% uranyl acetate. The temperature was then raised at a rate of 5"C/hr to 45'C; after washes in pure methanol, the samples were infiltrated with Lowicryl HM 20 and finally polymerized by UV light at -45'C for 2 days (van Genderen et al., 1991) . For LR White embedding, the samples were fixed with 1% glutaraldehyde in 0.1 M phosphate buffer for 30 min at 4'C. dehydrated up to 70% ethanol, and embedded in LR White, and polymerized at 0°C for 12 hr (Zini et al., 1993) .
Thin sections, carried out on nickel grids, were pre-incubated with 5% NGS in 0.05 M Tris-HC1. pH 7.6, with 0.15 M NaCl and 0.1% BSA (TBS), or with 10% NGS/4% BSA as in Western blot experiments, and then in- To exclude crossreactivity of KT 10 MAb with histones, the following procedures were used: (a) pre-incubation of KT 10 MAb with histones (Sigma); (b) incubation on the section with 1:30 anti-histone MAb (anti-H1 and core histones 1 6 2 M A b Chemicon), then incubation with 1:lO rabbit IgG Fab fragment against mouse I@ (RAM Fab) not conjugated with gold for 1 hr, before the incubation with 1:lOO KT 10 MAb and GAM conjugated with IO-nm colloidal gold.
The specificity of the immunorcaction was assessed as follows. PIP2 was removcd by pre-incubating nuclear matrix sections with a nuclear lysate that exhibited a marked polyphosphoinositidax activity on PIP and PIP2 in vitro (Martelli et al., 1992) . or by chloroform:methanol(1:2) extraction.
Quantitative evaluation was done by calculating the label density, i.e., the number of colloidal gold particles found per unit area. The results obtained from at least 100 individual fields are expressed as means * SD.
Results

Immunoblotting and Immunoprec2;bitation
Because we were interested in evaluating quantitatively the variations in the amount of the intranuclear PIPI, controls were performed to exclude possible crossreactivities that could interfere with the interpretation of the results. In immunoblots, in which Friend cell nuclear proteins were incubated with KT 10 MAb, a degree of positivity was found in the low molecular weight region that corresponds to histone H1 and core histones when 5% dried milk was used during the saturation steps. No reaction was found in these regions when the strips were saturated with 10% NGS14% BSA ( Figure 11 ). Furthermore, pre-fixation of the strips with 1% glutaraldehyde resulted in a specific staining ( Figure III) , and, as indicated by dot blots, the saturation procedure did not interfere with the specific recognition of PIP2 ( Figure 1111 ). These results demonstrate that the aspecific reaction with histones can be elimi-nated by a saturation treatment. We also found, by an immunoprecipitation assay in which KT 10 MAb had been reacted with a mixture of whole histones, that the immunoprecipitate was exclusively composed of the heavy and light chains of the antibody itself, and no proteins corresponding to histone molecular weight were detected ( Figure W ) .
Con focal Microscope Immunofluorescence
In isolated rat liver nuclei incubated with anti-PIP2 KT 10 MAb.
the immunofluorescence localization is procedure-dependent. In nuclear samples obtained without detergents, the nuclear membranes were not removed and a fluorescent halo was detected by confocal microscopy all around the nuclear surface, whereas the nucleoplasm was completely negative (Figure 2a ). Conversely, when nuclear membranes were removed by detergents during the isolation procedure, fluorescence was present only within the nucleoplasm (Figure 2b ). When isolated nuclei were permeabilized with detergents after fixation or by freezing and thawing, the fluorescence appeared to be present not only at the nuclear membrane but as0 diffused throughout the nucleoplasm (Figures 2c-2d ). This indicates that PIP2 antigenic sites exist within the nucleus, but that they can be reached by the antibody only after removal or permeabilization of the nuclear membranes.
Electron Microscopic Immunocytochemistry
The KT 10 MAb has been used on thin sections of rat pancreas 
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labeling being present on the same cell structures, i.e., the rough endoplasmic reticulum and the cell and nuclear membranes. Quantitative evaluation indicated that the heterochromatin presented a labeling whose intensity was twice than that of the interchromatin. The interchromatin granules and the granular component of the nucleolus were almost unlabeled (Figures 3a and 3b) . In both cases the background was negligible, since the collagen fibers, erythrocytes, mitochondria, and zymogen granules were almost unlabeled.
In isolated Friend cell nuclei, localization of the labeling was present at the same sites in Lowicryl HM 20 ( Figure 4a ) and in LR White resin-embedded samples (Figure 4b ). In particular, the labeling intensity of the peripheral and the nucleolus-associated heterochromatin was almost double that of the interchromatin regions. The central part of the nucleolus and the interchromatin granules were sparsely labeled. Although immunoblotting and immunoprecipitation experiments appeared to exclude crossreactivity of the anti-PIP2 with histones, this could not be completely ruled out under different experimental conditions, such as those of a post-embedding inmunogold reaction. To exclude this possibility, the following controls were performed. Pre-incubation of KT 10 MAb with PIP2 completely abolished the labeling (Figure sa) , whereas preincubation of KT 10 MAb with histones had no effect on the labeling intensity (Figure 5b) , with respect to the samples incubated only with KT 10 MAb (Figure 4b) . Moreover, when samples were incubated with anti-histone MAb and then with RAM Fab not conjugated with gold, and finally with gold-conjugated GAM, no labeling was obtained ( Figure %) , demonstrating that the block procedure was effective. The same procedure performed without the incubation with KT 10 MAb before the gold-conjugated GAM showed that the labeling intensity ( Figure 5d ) was not reduced compared with samples incubated only with KT 10 MAb (Figure 4b) . In all cases, pre-incubation of the grids either with 5% NGS/O.l% BSA or with 10% NGS/4% BSA gave similar quantitative labeling. However, when a sample was incubated with both anti-PIP2 and anti-histone MAbs, using colloidal gold particles of different sizes, the two labelings were present in the same nuclear areas. However, the labeling due to the anti-PIP2 MAb was prevailingly present in the peripheral and nucleolus-associated heterochromatin and, although less intense, in the interchromatin areas. Both labelings were absent on interchromatin granules and on the inner part of the nucleolus. Conversely, the labeling due to the anti-histone MAb was mainly localized in the interchromatin areas (Figures 6a and  6b) . The intensity of the labeling with KT 10 was lower compared with single labeling (Figure 4b ), since the incubation was done by floating the grid on the MAb (labeling on one grid face) and not by immersion (labeling on both grid faces).
To determine whether PIP2 remains associated with subnuclear fractions, nuclear matrices were obtained by extraction procedures on isolated nuclei that remove the nuclear membranes with detergents, the bulk of DNA with DNAse;and the nuclear soluble proteins with high ionic strength solutions (Berezney, 1984) . The immunogold labeling with anti-PIP2 on Friend cell nuclear matrices indicated that a certain amount of labeling remains associated with the inner nuclear matrix and with the peripheral part of the nucleolar remnant (Figure 7a ). This could be due to incomplete extraction of the nucleolus-associated heterochromatin. The labeling on the inner nuclear matrix, however. indicated that PIP2 is, at least in part, associated with the insoluble structures of the nuclear matrix, as previously suggested for the whole set of phospholipids identified by phospholipase A2 (PLA+gold labeling (Maraldi et al., 1992; Zini et al., 1989) , at the same sites in which a specific nuclear phospholipase C isoform has been detected (Zini et al., 1993) . When PIP2 was removed by organic solvents, the structural organization of the nuclear matrix was greatly affected but no immunogold labeling was detected (Figure 7b ). Moreover, when nuclear matrix thin sections were pre-incubated with a nuclear lysate that has been shown to have phosphoinositidase activity on PIP2 under in vitro conditions (Martelli et al., 1992) , a significant reduction of the nuclear labeling with anti-PIP2 antibody occurred compared with the controls (Figure 7c ). When glass-adherent cells, such as Swiss 3T3 mouse fibroblasts, are treated with detergents and high salt buffers, in situ matrix preparations are obtained (Fey et al., 1984) in which the nuclear matrix and the residual cytoskeleton are present side by side. In these samples, the immunolocalization of PIP2 was detectable in the threads of the inner nuclear matrix and in the filaments of the cytoskeleton (Figure 7d ).
Variations in the nuclear content of PIP2 have been reported to occur in Friend cells induced to undergo erythroid differentiation by DMSO. Under these conditions, down-regulation of the nuclear PIC p activity, accompanied by a decrease of the breakdown product of PIP2, i.e., DG, has been described (Billi et al., 1993) . A significant increase of PIP2 occurred in nuclei of DMSOtreated Friend cells compared with untreated cells (Figures 8a and  8b) ; quantitative evaluations indicated that the label density varies from 35 f 8 in untreated to 65 11 in DMSO-treated nuclei. These results demonstrate that the method is sensitive enough to detect quantitative variations of PIP2 after a differentiating stimulus. Figure 4b) . Fab not conjugated with gold and by gold-conjugated GAM. (d) two differently sized gold particles are identified by circles of different diameter (small, anti-histone; large, anti-PIPZ) . B a n = 1 pm.
(c) No label is present when the section is incubated with anti-histone MAb, followed by RAM
Discussion
The contention that nuclei contain significant amounts ofPIP2 and PIP is based both on metabolic experiments demonstrating that nuclei can sustain polyphosphoinositide synthesis and hydrolysis (Imine and Divecha, 1992; Cocco et al., 1988 Cocco et al., ,1989 Smith and Wells, 1983) , and on mass assay experiments (Tran et al., 1993; Divecha et al., 1991) . Moreover, changes in the polyphosphoinositide cycle can be induced by agonists in membrane-deprived nuclei (Martelli et al.. 1992; Divecha et al., 1991; Cocco et al., 1989) . The precise localization of PIP2 in the nucleus, however, is still controversial, since it has been reported to be associated with the nuclear envelope by immunofluorescence microscopy (Tran et al., 1993) but also with chromatin domains by electron microscopic immunogold labeling (Voorhout et al., 1992) . The immunofluorescence localization of PIP2 appears to be procedure-dependent. In fact, in isolated hepatocytes, after freezing and thawing, the nuclear membranes and the nucleoplasm are negative, despite the high fluorescence at the plasma membrane and in the cytoplasm, whereas in isolated nuclei not subjected to freezing and thawing, the reaction appears to be limited to the nuclear envelope (Tran et al., 1993) .
This suggests that the freezing and thawing procedure has enabled the antibody to reach the cell interior but not the nucleoplasm. On the other hand, the fluorescent halo observed in nonpermeabilized isolated nuclei indicates that PIP2 is present in the nuclear membranes, but this does not imply that PIP2 is not present within the nucleoplasm. In fact, the results reported here indicate that, in membrane-deprived nuclei or in nuclei whose membranes have been permeabilized with detergents or with freezing and thawing, intense fluorescence is also present in the nuclear interior.
Thus far, the cytochemical identification of intracellular phospholipids at the electron microscopic level has been hampered by the lack of reliable techniques. The main drawback is the possible removal or translocation of phospholipids during the embedding procedure. Even cryosections, which are successfully employed for immunodetection of protein antigens, are not very suitable for phospholipid identification, owing to the scarce preservation of lipidcontaining structures in frozen sections exposed to thawing before the immunoreaction (Voorhout et al., 1992) .
It has been previously demonstrated that intracellular phospholipids can be identified by an enzyme-gold technique based on the use of gold-conjugated phospholipase A2 (Coulombe et al., 1988) . We have further characterized the fine localization of phospholipids in cytoplasmic and nuclear sites by using different experimental approaches, such as cryofixation, cryosections, critical point drying-fracture label, thin section fracture-label, and resinembedded sections (Maraldi et al., 1992) .
The results reported here indicate that comparable results can be obtained by two embedding procedures. One is freeze-substitution Lowicryl HM 20 low-temperature embedding of aldehydefixed cryoprotccted samples (van Genderen et al., 1991) ; the other is partial dehydration and 0°C embedding in LR White ofaldehydefixed samples. In both cases, the immunolocalization with anti-PIP2 antibody occurred at the same sites. Since the LR White embedding procedure is very quick compared with the longlasting Lowicryl embedding, we used LR White low-temperature embedding after partial dehydration up to 70% ethanol.
Because our main interest was focused on identification of the intranuclear sites of PIP2 and on evaluation of possible quantitative variations of its content in given experimental conditions, the specificity and the sensitivity of the immunoreaction were critical. In particular, any possible crossreactivity with constitutive elements of the nucleus was extensively investigated.
It has been previously reported that MAb KT 10 did not react with any protein in Western blot analysis (Voorhout et al., 1992; Fukami et al., 1988; Miyazawa et al., 1988) . We have further investigated the possibility that KT 10 could react with nuclear proteins by Western blotting and immunoprecipitation tests and have shown that no nuclear proteins are recognized by the antibody, provided that aspecific reaction with histones is prevented by BSA and NGS.
However, because the immunogold detection of PIP2 is based on the use of post-embedding reactions on thin sections of plasticembedded samples, we further tested the specificity of the reaction under these conditions. Pre-incubation of the MAb with PIP2 and removal of PIP2 by organic solvents or by a nuclear extract that exhibited a phosphoinositidase activity (Martelli et al., 1992) caused an almost complete disappearance of the labeling. Furthermore, the occupancy of antigenic sites identified by the anti-histone MAb, followed by their block with RAM Fab not conjugated with gold before the identification of PIP2, does not interfere with the labeling, which appears not to be reduced compared with the controls. Moreover, the removal of DNA and many other nuclear proteins that occurs in nuclear matrix preparations does not abolish the immunolabeling of PIP2, which therefore appears to be partly bound to the residual nuclear matrix. It cannot be excluded, however, that the extraction procedures cause a partial redistribution of the nuclear PIP2, which could account for the prevalent presence of the labeling in the peripheral part of the nucleolar remnant, or that the nucleolus-associated heterochromatin is not completely removed by the extraction procedure.
Taken together, these experimental findings confirm that the anti-PIP2 antibody is specific and that the identification of PIP2 within the nucleus is reliable. Some aspects of this identification, however, present some unexpected features. In fact, the amount of labeling found in the nucleus apparently exceeds the level found on cytoplasmic membranes. A possible explanation is that the orientation of PIP2 molecules, either in membrane bilayers or in a lipid-protein complex within the nucleoplasm, could affect the efficiency of the immunolabeling (Voorhout et al., 1992) . A similar behavior has been previously reported for phospholipase Az-gold detection of phospholipids; the efficiency of the labeling greatly depended on the orientation of the phospholipid molecules in the liposomes, being higher in the apparently amorphous inner core within the liposomes than in the perpendicularly sectioned lamellar stacks (Maraldi et al., 1992) . On the other hand, the actual nature of the lipid-protein complexes which are present within the nucleus has not been elucidated, although the nuclear protein matrix would be the best candidate for this interaction (Divecha et al., 1993) . It is conceivable, therefore, that PIP2, which is linked in a fixed orientation to the cytoplasmic leaflet of the plasma membrane or of a cytoplasmic organelle, should be less accessible to the antibody than PIP2 associated with the nuclear matrix proteins, on the surface of which it should be partially buried in some hydrophobic clefts through its hydrophobic tails (Voorhout et al., 1992) . Moreover, according to a database search, many nuclear proteins, including histones, DNA polymerases and topoisomerases, RNA polymerases, nucleolar and DNA-binding proteins, and nuclear matrix proteins, present a polyphosphoinositide-binding consensus sequence (data not shown), which has been identified in the actin-binding domain of gelsolin (Yu et al., 1992) . It is therefore likely that PIP2 can be identified by KT 10 MAb in different nuclear domains at which nuclear proteins that have polyphosphoinositide-binding sites are present.
The efficiency of the immunocytochemical detection of an antigen depends on whether it is randomly diffused in a given cell district or is preferentially bound to a membrane surface (Stierhof et al., 1991; Kellenberger et al., 1987) . The amount of PIP2 has been estimated as 3.4 nmollmg protein in the cell membrane, which is 0.3% of total membrane phospholipids (Tran et al., 1993) . Therefore, -15,000 PIP2 molecules are present per pm2 of membrane, which corresponds to m30 PIP2 molecules per linear pm of a sectioned membrane profile. The experimentally observed labeling density of about five gold particles per linear pm is compatible with a 0.1-0.5 yield, which occurs for membrane-associated antigens (Stierhof et al., 1991) . The amount of nuclear PIP2 has been determined to be about 0.5 nmol/mg nuclear protein (Tran et al., 1993) , meaning that each nucleus contains about 30,000 PIP2 molecules. Since PIP2 is not uniformly distributed but is mainly linked to the inner nuclear matrix, which represents a fraction of the nuclear volume, the observed labeling density is compatible with the number of antigenic sites bound to this nuclear component and with the yield reported for antigens associated with confined areas (Kellenberger et al., 1987) .
The immunolabeling detection of PIP2 with KT 10 MAb appears to be sensitive enough to detect quantitative variations in the PIP2 content that occur within the nucleus under experimental conditions. In Friend cells induced to erythroid differentiation, down-regulation of nuclear PIC p activity causes an increased accumulation of PIP2 in the nucleus (Billi et al., 1993) . With this experimental model, the amount of nuclear PIP2 detectable by immunogold labeling has been found to be higher in DMSOdifferentiated cells than in control samples. This confirms that the immunolabeling technique is sensitive enough to be utilized for quantitative studies of PIP2 distribution.
The immunocytochemical data on in situ matrix preparations demonstrate that PIP2 is not only membrane-associated but is also bound to cell skeletal structures, such as the cytoskeletal filaments and the inner nuclear matrix. Both of these subcellular structures have been shown to be involved in the complex signal transduction cascade. The PIP2 association with cytoskeletal filaments is in agreement with the detection at the same sites of PIC y (Zini et al., 1993) . This accounts for the regulatory role played by the signal transduction system in cytoskeletal actin filament polymerization (Stossel, 1989) , thus suggesting that the entire cell skeleton provides the basis for a coordinate response to exogenous signals. On the other hand, the nucleus is considered to be the site of a polyphosphoinositide cycle that is entirely separate from the cycle that exists at the plasma membrane (Divecha et al., 1993) . The finding of PIP2 localization in the nuclear matrix is in agreement with the recent contention that specific nuclear phospholipase C and PKC are also nuclear matrix-associated (Zini et al., 1993) , demonstrating the presence of an autonomous polyphosphoinositide cycle at the nuclear level.
